Unitypoint Health - Trinity Rock Island

Patient Safety - All

Healthcare-Associated Infections

Hospitals in Illinois are participating in programs to reduce the number of infections acquired during hospital stays. While it is difficult to reduce infections to zero, following specific protocols can greatly reduce the risk.

The Hospital Report Card Act (Illinois Public Act 93-563) requires Illinois hospitals to report central line associated bloodstream infections (CLABSIs) as well as surgical site infections (SSIs). As of January 1, 2012, hospitals are also mandated to report Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections and Clostridioides difficileinfections. Infections are reported through the CDC’s National Healthcare Safety Network (NHSN) surveillance system. The Standardized Infection Ratio (SIR) , a summary measure used to determine whether infection data are statistically different from the national average, is presented for each type of infection shown below. Read more about healthcare-associated infections in Illinois . To learn more about the data collection methods using the CDC's National Health Safety Network (NHSN) surveillance system, read the Report Card methodology .

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Central Line Associated Bloodstream Infections (CLABSIs)

Presented below are annual central line-associated bloodstream infections (CLABSIs) occurring in critical care units, also known as intensive care units (ICUs). ICU-specific summary data for CLABSI are provided using the Standardized Infection Ratio(SIR) . Statewide summaries of CLABSI data arranged by ICU type and hospital are also included.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Adult CLABSI

Pediatric CLABSI

Ped. CLABSI Measure	Result	SIR
Pediatric Medical-Surgical ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection (CLABSI) data in the Medical-Surgical Pediatric ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2013 - Q4 2013 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2012 - Q4 2012 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: N/A ³⁸	N/A infections, N/A central-line days ³⁸	N/A ³⁸
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁸ Rating SIR: 0.00 ³⁸	N/A infections, N/A central-line days ³⁸	0.00 ³⁸

NICU CLABSI

Surgical Site Infections (SSIs)

Presented below are data for surgical site infections associated with coronary artery bypass graft surgery (CABG) and total knee replacement surgery (KPROs) using the Standardized Infection Ratio (SIR) . Superficial and secondary surgical site infections are not included in the summary data below. Statewide summaries of surgical site infection data arranged by surgical procedure ( CABG , KPRO ) and hospital are also included.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Immunization Practices

Illinois hospitals are focusing their efforts on boosting immunization treatments and strengthening patient safety protocols. The objective is not merely achieving statistical success, but also enhancing the quality of care and patient well-being.

Data on immunization measures in Illinois hospitals is available through the Medicare comparison tool at medicare.gov/hospitalcompare . This tool provides valuable insights, allowing patients and their families to gauge the quality of care and safety practices at local hospitals, helping them make informed healthcare decisions.

In the realm of Patient Safety, a host of measures are assessed, with risk-adjusted rates available for each. These measures encompass various aspects of patient care and treatment outcomes. However, interpreting these metrics requires an understanding of the complexity and context-specific nature of healthcare.

Immunization

These indicators are used to measure immunization treatments at hospitals. This data comes from medicare.gov/hospitalcompare .

Measure	Result
Healthcare workers given influenza vaccination Q4 2022 - Q1 2023 Result 82.00 %	82.00 %
Description Influenza Vaccination Coverage among Healthcare Personnel Historical Data
Measure	Result
Q4 2021 - Q1 2022 Result 90.00 %	90.00 %
Q4 2020 - Q1 2021 Result 81.00 %	81.00 %
Q4 2019 - Q1 2020 Result N/A %	N/A %
Q4 2018 - Q1 2019 Result 92.00 %	92.00 %
Q4 2017 - Q1 2018 Result 88.00 %	88.00 %

Patient Safety

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Key	Description
33	Complete Reporting: 50 or Less Central Line Days
38	Exempt: No Licensed PICU Beds
39	Exempt: No Licensed NICU Beds
42	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
43	Complete Reporting: Zero infections, but too few central line days to calculate a precise SIR
44	Complete Reporting: Too few central line days to calculate a precise SIR
46	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
117	Complete Reporting: Zero infections. Number of reported events is not significantly different than predicted
118	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
153	Complete Reporting: Zero infections. Number of predicted events too low to calculate a precise SIR
169	Exempt: No Licensed ICU Beds

Measure	Risk-Adjusted Rate
Postoperative Lung Embolism or Deep Vein Thrombosis (clotting) Q4 2021 - Q3 2022 Rating SIR: 0.71	0.71
Description The number of cases of deep vein thrombosis or pulmonary embolism per 1,000 surgical discharges (PSI 12). Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 1.31	1.31
Q4 2019 - Q3 2020 Rating SIR: 2.23	2.23
Q4 2018 - Q3 2019 Rating SIR: 3.80	3.80
Q2 2018 - Q1 2019 Rating SIR: 4.96	4.96
Q1 2015 - Q4 2015 Rating SIR: 2.38	2.38
Q4 2014 - Q3 2015 Rating SIR: 2.64	2.64
Q1 2014 - Q4 2014 Rating SIR: 3.03	3.03
Q4 2013 - Q3 2014 Rating SIR: 2.49	2.49
Q1 2013 - Q4 2013 Rating SIR: 4.50	4.50
Q3 2012 - Q2 2013 Rating SIR: 3.27	3.27
Q1 2012 - Q4 2012 Rating SIR: 3.81	3.81
Q4 2011 - Q3 2012 Rating SIR: 3.66	3.66
Q2 2011 - Q1 2012 Rating SIR: 0.15	0.15
Q1 2011 - Q4 2011 Rating SIR: 1.39	1.39
Q4 2010 - Q3 2011 Rating SIR: 2.15	2.15
Q1 2010 - Q4 2010 Rating SIR: 3.40	3.40
Q4 2009 - Q3 2010 Rating SIR: 2.88	2.88
Q1 2009 - Q4 2009 Rating SIR: 1.85	1.85
Q3 2008 - Q2 2009 Rating SIR: 1.40	1.40
Q1 2008 - Q4 2008 Rating SIR: 2.00	2.00
Wound Complications in Abdominal Wall Surgery Q4 2021 - Q3 2022 Rating SIR: 0.00	0.00
Description The number of cases of reclosure of postoperative disruption of abdominal wall per 1,000 cases of abdominopelvic surgery. (PSI 14) Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 0.00	0.00
Q4 2019 - Q3 2020 Rating SIR: 1.34	1.34
Q4 2018 - Q3 2019 Rating SIR: 0.00	0.00
Q2 2018 - Q1 2019 Rating SIR: 0.00	0.00
Q1 2015 - Q4 2015 Rating SIR: 4.77	4.77
Q4 2014 - Q3 2015 Rating SIR: 6.80	6.80
Q1 2014 - Q4 2014 Rating SIR: 0.00	0.00
Q4 2013 - Q3 2014 Rating SIR: 0.00	0.00
Q1 2013 - Q4 2013 Rating SIR: 0.00	0.00
Q3 2012 - Q2 2013 Rating SIR: 0.00	0.00
Q1 2012 - Q4 2012 Rating SIR: 0.00	0.00
Q4 2011 - Q3 2012 Rating SIR: 1.30	1.30
Q2 2011 - Q1 2012 Rating SIR: 1.22	1.22
Q1 2011 - Q4 2011 Rating SIR: 9.70	9.70
Q4 2010 - Q3 2011 Rating SIR: 2.29	2.29
Q1 2010 - Q4 2010 Rating SIR: 1.08	1.08
Q4 2009 - Q3 2010 Rating SIR: 0.00	0.00
Q1 2009 - Q4 2009 Rating SIR: 2.28	2.28
Q3 2008 - Q2 2009 Rating SIR: 0.00	0.00
Q1 2008 - Q4 2008 Rating SIR: 0.00	0.00
Accidental Puncture and Laceration Q4 2021 - Q3 2022 Rating SIR: 0.00	0.00
Description The number of cases of accidental cut, puncture, perforation, or laceration during procedure per 1,000 discharges. (PSI 15) Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 0.00	0.00
Q4 2019 - Q3 2020 Rating SIR: 0.00	0.00
Q4 2018 - Q3 2019 Rating SIR: 0.72	0.72
Q2 2018 - Q1 2019 Rating SIR: 1.63	1.63
Q1 2015 - Q4 2015 Rating SIR: 1.98	1.98
Q4 2014 - Q3 2015 Rating SIR: 2.87	2.87
Q1 2014 - Q4 2014 Rating SIR: 1.48	1.48
Q4 2013 - Q3 2014 Rating SIR: 0.95	0.95
Q1 2013 - Q4 2013 Rating SIR: 1.40	1.40
Q3 2012 - Q2 2013 Rating SIR: 1.29	1.29
Q1 2012 - Q4 2012 Rating SIR: 2.91	2.91
Q4 2011 - Q3 2012 Rating SIR: 3.10	3.10
Q2 2011 - Q1 2012 Rating SIR: 0.42	0.42
Q1 2011 - Q4 2011 Rating SIR: 4.63	4.63
Q4 2010 - Q3 2011 Rating SIR: 3.77	3.77
Q1 2010 - Q4 2010 Rating SIR: 2.86	2.86
Q4 2009 - Q3 2010 Rating SIR: 3.83	3.83
Q1 2009 - Q4 2009 Rating SIR: 4.22	4.22
Q3 2008 - Q2 2009 Rating SIR: 3.10	3.10
Q1 2008 - Q4 2008 Rating SIR: 2.90	2.90
Collapsed Lung caused by Medical Care Q4 2021 - Q3 2022 Rating SIR: 0.12	0.12
Description This measure is used to assess the number of cases of collapsed lung caused by medical care per 1,000 patients. (PSI 06) Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 0.40	0.40
Q4 2019 - Q3 2020 Rating SIR: 0.25	0.25
Q4 2018 - Q3 2019 Rating SIR: 0.09	0.09
Q2 2018 - Q1 2019 Rating SIR: 0.20	0.20
Q1 2015 - Q4 2015 Rating SIR: 0.34	0.34
Q4 2014 - Q3 2015 Rating SIR: 0.00	0.00
Q1 2014 - Q4 2014 Rating SIR: 0.34	0.34
Q4 2013 - Q3 2014 Rating SIR: 0.47	0.47
Q1 2013 - Q4 2013 Rating SIR: 0.20	0.20
Q3 2012 - Q2 2013 Rating SIR: 0.21	0.21
Q1 2012 - Q4 2012 Rating SIR: 0.28	0.28
Q4 2011 - Q3 2012 Rating SIR: 0.28	0.28
Q2 2011 - Q1 2012 Rating SIR: 0.07	0.07
Q1 2011 - Q4 2011 Rating SIR: 3.79	3.79
Q4 2010 - Q3 2011 Rating SIR: 0.56	0.56
Q1 2010 - Q4 2010 Rating SIR: 0.08	0.08
Q4 2009 - Q3 2010 Rating SIR: 0.20	0.20
Q1 2009 - Q4 2009 Rating SIR: 0.64	0.64
Q3 2008 - Q2 2009 Rating SIR: 0.30	0.30
Q1 2008 - Q4 2008 Rating SIR: 0.30	0.30
Postoperative Hemorrhage or Hematoma Q4 2021 - Q3 2022 Rating SIR: 2.80	2.80
Description The number of cases of hematoma or hemorrhage requiring a procedure per 1,000 surgical discharges. (PSI 09) Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 1.36	1.36
Q4 2019 - Q3 2020 Rating SIR: 1.25	1.25
Q4 2018 - Q3 2019 Rating SIR: 0.90	0.90
Q2 2018 - Q1 2019 Rating SIR: 1.41	1.41
Q1 2015 - Q4 2015 Rating SIR: 3.91	3.91
Q4 2014 - Q3 2015 Rating SIR: 4.09	4.09
Q1 2014 - Q4 2014 Rating SIR: 9.62	9.62
Q4 2013 - Q3 2014 Rating SIR: 8.79	8.79
Q1 2013 - Q4 2013 Rating SIR: 4.63	4.63
Q3 2012 - Q2 2013 Rating SIR: 5.03	5.03
Q1 2012 - Q4 2012 Rating SIR: 6.02	6.02
Q4 2011 - Q3 2012 Rating SIR: 1.16	1.16
Q2 2011 - Q1 2012 Rating SIR: 2.19	2.19
Q1 2011 - Q4 2011 Rating SIR: 1.65	1.65
Q4 2010 - Q3 2011 Rating SIR: 2.52	2.52
Q1 2010 - Q4 2010 Rating SIR: 1.85	1.85
Q4 2009 - Q3 2010 Rating SIR: 1.55	1.55
Q1 2009 - Q4 2009 Rating SIR: 2.41	2.41
Q3 2008 - Q2 2009 Rating SIR: 0.17	0.17
Q1 2008 - Q4 2008 Rating SIR: 0.03	0.03
Postoperative Respiratory Failure Q4 2021 - Q3 2022 Rating SIR: 2.53	2.53
Description The number of cases of acute respiratory failure per 1,000 elective surgical discharges. (PSI 11) Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 10.72	10.72
Q4 2019 - Q3 2020 Rating SIR: 8.23	8.23
Q4 2018 - Q3 2019 Rating SIR: 7.75	7.75
Q2 2018 - Q1 2019 Rating SIR: 10.16	10.16
Q1 2015 - Q4 2015 Rating SIR: 9.36	9.36
Q4 2014 - Q3 2015 Rating SIR: 7.44	7.44
Q1 2014 - Q4 2014 Rating SIR: 9.54	9.54
Q4 2013 - Q3 2014 Rating SIR: 7.80	7.80
Q1 2013 - Q4 2013 Rating SIR: 11.29	11.29
Q3 2012 - Q2 2013 Rating SIR: 15.01	15.01
Q1 2012 - Q4 2012 Rating SIR: 10.32	10.32
Q4 2011 - Q3 2012 Rating SIR: 10.32	10.32
Q2 2011 - Q1 2012 Rating SIR: 11.90	11.90
Q1 2011 - Q4 2011 Rating SIR: 14.75	14.75
Q4 2010 - Q3 2011 Rating SIR: 15.63	15.63
Q1 2010 - Q4 2010 Rating SIR: 10.66	10.66
Q4 2009 - Q3 2010 Rating SIR: 20.28	20.28
Q1 2009 - Q4 2009 Rating SIR: 19.06	19.06
Q3 2008 - Q2 2009 Rating SIR: 0.78	0.78
Q1 2008 - Q4 2008 Rating SIR: 0.66	0.66
Postoperative Hip Fracture Q4 2021 - Q3 2022 Rating SIR: 0.18	0.18
Description The number of cases of in-hospital hip fracture per 1,000 surgical discharges(PSI 08). Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 0.00	0.00
Q4 2019 - Q3 2020 Rating SIR: 0.00	0.00
Q4 2018 - Q3 2019 Rating SIR: 0.00	0.00
Q2 2018 - Q1 2019 Rating SIR: 0.00	0.00
Q1 2015 - Q4 2015 Rating SIR: 0.00	0.00
Q4 2014 - Q3 2015 Rating SIR: 0.00	0.00
Q1 2014 - Q4 2014 Rating SIR: 0.00	0.00
Q4 2013 - Q3 2014 Rating SIR: 0.00	0.00
Q1 2013 - Q4 2013 Rating SIR: 0.00	0.00
Q3 2012 - Q2 2013 Rating SIR: 0.70	0.70
Q1 2012 - Q4 2012 Rating SIR: 0.64	0.64
Q4 2011 - Q3 2012 Rating SIR: 0.00	0.00
Q2 2011 - Q1 2012 Rating SIR: 0.00	0.00
Q1 2011 - Q4 2011 Rating SIR: 0.00	0.00
Q4 2010 - Q3 2011 Rating SIR: 0.00	0.00
Q1 2010 - Q4 2010 Rating SIR: 0.00	0.00
Q4 2009 - Q3 2010 Rating SIR: 0.00	0.00
Q1 2009 - Q4 2009 Rating SIR: 0.00	0.00
Q3 2008 - Q2 2009 Rating SIR: 0.00	0.00
Q1 2008 - Q4 2008 Rating SIR: 0.00	0.00
Pressure Ulcer Q4 2021 - Q3 2022 Rating SIR: 0.23	0.23
Description The number of cases of pressure ulcer per 1,000 discharges with a length of stay greater than 4 days (PSI 03). Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 0.46	0.46
Q4 2019 - Q3 2020 Rating SIR: 0.44	0.44
Q4 2018 - Q3 2019 Rating SIR: 0.14	0.14
Q2 2018 - Q1 2019 Rating SIR: 0.30	0.30
Q1 2015 - Q4 2015 Rating SIR: 0.00	0.00
Q4 2014 - Q3 2015 Rating SIR: 0.00	0.00
Q1 2014 - Q4 2014 Rating SIR: 0.00	0.00
Q4 2013 - Q3 2014 Rating SIR: 0.77	0.77
Q1 2013 - Q4 2013 Rating SIR: 0.74	0.74
Q3 2012 - Q2 2013 Rating SIR: 0.00	0.00
Q1 2012 - Q4 2012 Rating SIR: 0.39	0.39
Q4 2011 - Q3 2012 Rating SIR: 0.24	0.24
Q2 2011 - Q1 2012 Rating SIR: 0.29	0.29
Q1 2011 - Q4 2011 Rating SIR: 2.55	2.55
Q4 2010 - Q3 2011 Rating SIR: 1.18	1.18
Q1 2010 - Q4 2010 Rating SIR: 0.32	0.32
Q4 2009 - Q3 2010 Rating SIR: 3.29	3.29
Q1 2009 - Q4 2009 Rating SIR: 1.08	1.08
Q3 2008 - Q2 2009 Rating SIR: 0.14	0.14
Q1 2008 - Q4 2008 Rating SIR: 0.28	0.28
Postoperative Sepsis Q4 2021 - Q3 2022 Rating SIR: 2.06	2.06
Description The number of cases of sepsis per 1,000 elective surgery patients with a length of stay of 4 days or more (PSI 13). Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 0.00	0.00
Q4 2019 - Q3 2020 Rating SIR: 4.39	4.39
Q4 2018 - Q3 2019 Rating SIR: 3.65	3.65
Q2 2018 - Q1 2019 Rating SIR: 5.36	5.36
Q1 2015 - Q4 2015 Rating SIR: 14.01	14.01
Q4 2014 - Q3 2015 Rating SIR: 7.36	7.36
Q1 2014 - Q4 2014 Rating SIR: 2.66	2.66
Q4 2013 - Q3 2014 Rating SIR: 12.26	12.26
Q1 2013 - Q4 2013 Rating SIR: 6.85	6.85
Q3 2012 - Q2 2013 Rating SIR: 9.90	9.90
Q1 2012 - Q4 2012 Rating SIR: 14.74	14.74
Q4 2011 - Q3 2012 Rating SIR: 10.48	10.48
Q2 2011 - Q1 2012 Rating SIR: 9.39	9.39
Q1 2011 - Q4 2011 Rating SIR: 9.41	9.41
Q4 2010 - Q3 2011 Rating SIR: 9.46	9.46
Q1 2010 - Q4 2010 Rating SIR: 2.54	2.54
Q4 2009 - Q3 2010 Rating SIR: 7.11	7.11
Q1 2009 - Q4 2009 Rating SIR: 6.45	6.45
Q3 2008 - Q2 2009 Rating SIR: 0.71	0.71
Q1 2008 - Q4 2008 Rating SIR: 1.70	1.70
Postoperative Acute Kidney Injury Requiring Dialysis Q4 2021 - Q3 2022 Rating SIR: 1.36	1.36
Description This measure is used to assess the number of cases of specified physiological or metabolic derangement per 1,000 elective surgical discharges with an operating room procedure. (PSI 10) Historical Data
Measure	Result	Rating
Q4 2020 - Q3 2021 Rating SIR: 0.00	0.00
Q4 2019 - Q3 2020 Rating SIR: 1.52	1.52
Q4 2018 - Q3 2019 Rating SIR: 0.00	0.00
Q2 2018 - Q1 2019 Rating SIR: 1.39	1.39
Q1 2015 - Q4 2015 Rating SIR: 0.00	0.00
Q4 2014 - Q3 2015 Rating SIR: 1.34	1.34
Q1 2014 - Q4 2014 Rating SIR: 2.28	2.28
Q4 2013 - Q3 2014 Rating SIR: 1.13	1.13
Q1 2013 - Q4 2013 Rating SIR: 1.00	1.00
Q3 2012 - Q2 2013 Rating SIR: 0.00	0.00
Q1 2012 - Q4 2012 Rating SIR: 0.00	0.00
Q4 2011 - Q3 2012 Rating SIR: 0.00	0.00
Q2 2011 - Q1 2012 Rating SIR: 0.00	0.00
Q1 2011 - Q4 2011 Rating SIR: 0.00	0.00
Q4 2010 - Q3 2011 Rating SIR: 0.00	0.00
Q1 2010 - Q4 2010 Rating SIR: 0.00	0.00
Q4 2009 - Q3 2010 Rating SIR: 0.00	0.00
Q1 2009 - Q4 2009 Rating SIR: 0.00	0.00
Q3 2008 - Q2 2009 Rating SIR: 0.00	0.00
Q1 2008 - Q4 2008 Rating SIR: 0.04	0.04

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 6 infections, 49135 patient days Rating SIR: 1.91	6 infections, 49135 patient days	1.91
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 3 infections, 50146 patient days Rating SIR: 0.94	3 infections, 50146 patient days	0.94
Q1 2021 - Q4 2021 Result 2 infections, 53586 patient days Rating SIR: 0.48	2 infections, 53586 patient days	0.48
Q1 2020 - Q4 2020 Result 3 infections, 48971 patient days Rating SIR: 1.13	3 infections, 48971 patient days	1.13
Q1 2019 - Q4 2019 Result 3 infections, 51109 patient days Rating SIR: 0.98	3 infections, 51109 patient days	0.98
Q1 2018 - Q4 2018 Result 0 infections, 51543 patient days ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 51543 patient days ¹¹⁷	0.00 ¹¹⁷
Q1 2017 - Q4 2017 Result 4 infections, 56095 patient days Rating SIR: 1.19	4 infections, 56095 patient days	1.19
Q1 2016 - Q4 2016 Result 1 infections, 58156 patient days Rating SIR: 0.29	1 infections, 58156 patient days	0.29
Q1 2015 - Q4 2015 Result 1 infections, 60435 patient days Rating SIR: 0.39	1 infections, 60435 patient days	0.39
Q1 2014 - Q4 2014 Result 3 infections, 68833 patient days Rating SIR: 0.80	3 infections, 68833 patient days	0.80
Q1 2013 - Q4 2013 Result 1 infections, 79098 patient days Rating SIR: 0.31	1 infections, 79098 patient days	0.31
Q1 2012 - Q4 2012 Result 5 infections, 80958 patient days Rating SIR: 1.29	5 infections, 80958 patient days	1.29
Q1 2012 - Q2 2012 Result 1 infections, 40876 patient days Rating SIR: 0.24	1 infections, 40876 patient days	0.24
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 10 infections, 49135 patient days Rating SIR: 0.48	10 infections, 49135 patient days	0.48
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 8 infections, 50146 patient days Rating SIR: 0.33	8 infections, 50146 patient days	0.33
Q1 2021 - Q4 2021 Result 10 infections, 53586 patient days Rating SIR: 0.39	10 infections, 53586 patient days	0.39
Q1 2020 - Q4 2020 Result 15 infections, 48971 patient days Rating SIR: 0.63	15 infections, 48971 patient days	0.63
Q1 2019 - Q4 2019 Result 10 infections, 51109 patient days Rating SIR: 0.40	10 infections, 51109 patient days	0.40
Q1 2018 - Q4 2018 Result 39 infections, 51543 patient days Rating SIR: 0.88	39 infections, 51543 patient days	0.88
Q1 2017 - Q4 2017 Result 49 infections, 56095 patient days Rating SIR: 1.03	49 infections, 56095 patient days	1.03
Q1 2016 - Q4 2016 Result 45 infections, 58156 patient days Rating SIR: 1.02	45 infections, 58156 patient days	1.02
Q1 2015 - Q4 2015 Result 45 infections, 60435 patient days Rating SIR: 1.03	45 infections, 60435 patient days	1.03
Q1 2014 - Q4 2014 Result 51 infections, 68833 patient days Rating SIR: 0.91	51 infections, 68833 patient days	0.91
Q1 2013 - Q4 2013 Result 42 infections, 74387 patient days Rating SIR: 0.68	42 infections, 74387 patient days	0.68
Q1 2012 - Q4 2012 Result 44 infections, 76017 patient days Rating SIR: 0.74	44 infections, 76017 patient days	0.74

Adult CLABSI Measure	Result	SIR
Adult Surgical ICU Q1 2020 - Q4 2020 Result 0 infections, 1341 central-line days Rating SIR: 0.00	0 infections, 1341 central-line days	0.00
Description Central Line-associated Bloodstream Infection data in the Adult Surgical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 0 infections, 939 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 939 central-line days ⁴²	N/A ⁴²
Q1 2018 - Q4 2018 Result 0 infections, 929 central-line days ⁴² Rating SIR: N/A ⁴²	0 infections, 929 central-line days ⁴²	N/A ⁴²
Q1 2017 - Q4 2017 Result 1 infections, 1001 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 1001 central-line days ⁴⁴	N/A ⁴⁴
Q1 2016 - Q4 2016 Result 1 infections, 1011 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	1 infections, 1011 central-line days ⁴⁴	N/A ⁴⁴
Q1 2015 - Q4 2015 Result 1 infections, 1152 central-line days Rating SIR: 0.38	1 infections, 1152 central-line days	0.38
Q1 2013 - Q4 2013 Result 1 infections, 1181 central-line days Rating SIR: 0.37	1 infections, 1181 central-line days	0.37
Q1 2012 - Q4 2012 Result 3 infections, 1132 central-line days Rating SIR: 1.15	3 infections, 1132 central-line days	1.15
Q1 2011 - Q4 2011 Result 1 infections, 1163 central-line days Rating SIR: 0.37	1 infections, 1163 central-line days	0.37
Q1 2010 - Q4 2010 Result 0 infections, 1007 central-line days ⁴³ Rating SIR: 0.00 ⁴³	0 infections, 1007 central-line days ⁴³	0.00 ⁴³
Q1 2009 - Q4 2009 Result 0 infections, 896 central-line days Rating SIR: 0.00	0 infections, 896 central-line days	0.00
Adult Medical ICU Q1 2022 - Q4 2022 Result 4 infections, 3427 central-line days Rating SIR: 1.35	4 infections, 3427 central-line days	1.35
Description Central Line-associated Bloodstream Infection data in the Adult Medical ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2021 - Q4 2021 Result 7 infections, 3515 central-line days Rating SIR: 2.30	7 infections, 3515 central-line days	2.30
Q1 2020 - Q4 2020 Result 2 infections, 1466 central-line days Rating SIR: 1.57	2 infections, 1466 central-line days	1.57
Q1 2019 - Q4 2019 Result 1 infections, 1162 central-line days Rating SIR: 0.99	1 infections, 1162 central-line days	0.99
Q1 2018 - Q4 2018 Result 2 infections, 1058 central-line days ⁴⁴ Rating SIR: N/A ⁴⁴	2 infections, 1058 central-line days ⁴⁴	N/A ⁴⁴
Q1 2017 - Q4 2017 Result 2 infections, 1249 central-line days Rating SIR: 1.85	2 infections, 1249 central-line days	1.85
Q1 2016 - Q4 2016 Result 2 infections, 1165 central-line days Rating SIR: 1.98	2 infections, 1165 central-line days	1.98
Q1 2015 - Q4 2015 Result 2 infections, 1279 central-line days Rating SIR: 0.82	2 infections, 1279 central-line days	0.82
Q1 2014 - Q4 2014 Result 2 infections, 1298 central-line days Rating SIR: 0.81	2 infections, 1298 central-line days	0.81
Q1 2013 - Q4 2013 Result 1 infections, 1724 central-line days Rating SIR: 0.31	1 infections, 1724 central-line days	0.31
Q1 2012 - Q4 2012 Result 8 infections, 1312 central-line days Rating SIR: 3.21	8 infections, 1312 central-line days	3.21
Q1 2011 - Q4 2011 Result 0 infections, 1385 central-line days ⁴³ Rating SIR: 0.00 ⁴³	0 infections, 1385 central-line days ⁴³	0.00 ⁴³
Q1 2010 - Q4 2010 Result 2 infections, 1216 central-line days Rating SIR: 0.87	2 infections, 1216 central-line days	0.87
Q1 2009 - Q4 2009 Result 0 infections, 999 central-line days Rating SIR: 0.00	0 infections, 999 central-line days	0.00

NICU CLABSI Measure	Result	SIR
Level II/III Neonatal ICU Q1 2013 - Q4 2013 Result 0 infections, 44 central-line days ³³ Rating SIR: N/A ³³	0 infections, 44 central-line days ³³	N/A ³³
Description Central Line-associated Bloodstream Infection data in the Level II/III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2012 - Q4 2012 Result 0 infections, 1 central-line days ³³ Rating SIR: 0.00 ³³	0 infections, 1 central-line days ³³	0.00 ³³
Level III Neonatal ICU Q1 2019 - Q4 2019 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Description Central Line-associated Bloodstream Infection data in the Level III Neonatal ICU summarized as a Standardized Infection Ratio. Historical Data
Measure	Result	Rating
Q1 2018 - Q4 2018 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2017 - Q4 2017 Result N/A infections, N/A central-line days ¹⁶⁹ Rating SIR: N/A ¹⁶⁹	N/A infections, N/A central-line days ¹⁶⁹	N/A ¹⁶⁹
Q1 2016 - Q4 2016 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2015 - Q4 2015 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2014 - Q4 2014 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2011 - Q4 2011 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q4 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹
Q1 2010 - Q2 2010 Result N/A infections, N/A central-line days ³⁹ Rating SIR: N/A ³⁹	N/A infections, N/A central-line days ³⁹	N/A ³⁹

SSI Measure	Result	SIR
Total Knee Replacement Surgery Q1 2020 - Q4 2020 Result 2 infections, 296 procedures Rating SIR: 1.90	2 infections, 296 procedures	1.90
Description Surgical Site Infections Associated with Total Knee Replacement Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 0 infections, 330 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 330 procedures ¹¹⁷	0.00 ¹¹⁷
Q1 2018 - Q4 2018 Result 1 infections, 357 procedures Rating SIR: 0.84	1 infections, 357 procedures	0.84
Q1 2017 - Q4 2017 Result 1 infections, 366 procedures Rating SIR: 0.79	1 infections, 366 procedures	0.79
Q1 2016 - Q4 2016 Result 1 infections, 350 procedures Rating SIR: 0.97	1 infections, 350 procedures	0.97
Q1 2015 - Q4 2015 Result 1 infections, 435 procedures Rating SIR: 0.39	1 infections, 435 procedures	0.39
Q1 2014 - Q4 2014 Result 1 infections, 380 procedures Rating SIR: 0.44	1 infections, 380 procedures	0.44
Q3 2013 - Q2 2014 Result 2 infections, 334 procedures Rating SIR: 0.99	2 infections, 334 procedures	0.99
Q3 2012 - Q2 2013 Result 0 infections, 306 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 306 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2011 - Q2 2012 Result 2 infections, 332 procedures Rating SIR: 1.02	2 infections, 332 procedures	1.02
Q3 2010 - Q2 2011 Result 0 infections, 307 procedures ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 307 procedures ⁴⁶	0.00 ⁴⁶
Coronary Artery Bypass Graft Surgery Q1 2020 - Q4 2020 Result 0 infections, 103 procedures ¹¹⁸ Rating SIR: N/A ¹¹⁸	0 infections, 103 procedures ¹¹⁸	N/A ¹¹⁸
Description Surgical Site Infections Associated with Coronary Artery Bypass Graft Surgery Summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2019 - Q4 2019 Result 1 infections, 149 procedures Rating SIR: 0.97	1 infections, 149 procedures	0.97
Q1 2018 - Q4 2018 Result 0 infections, 150 procedures ¹⁵³ Rating SIR: N/A ¹⁵³	0 infections, 150 procedures ¹⁵³	N/A ¹⁵³
Q1 2016 - Q4 2016 Result 0 infections, 162 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 162 procedures ¹¹⁷	0.00 ¹¹⁷
Q1 2015 - Q4 2015 Result 0 infections, 189 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 189 procedures ¹¹⁷	0.00 ¹¹⁷
Q1 2014 - Q4 2014 Result 3 infections, 190 procedures Rating SIR: 1.39	3 infections, 190 procedures	1.39
Q3 2013 - Q2 2014 Result 1 infections, 170 procedures Rating SIR: 0.47	1 infections, 170 procedures	0.47
Q3 2012 - Q2 2013 Result 0 infections, 160 procedures ¹¹⁷ Rating SIR: 0.00 ¹¹⁷	0 infections, 160 procedures ¹¹⁷	0.00 ¹¹⁷
Q3 2011 - Q2 2012 Result 0 infections, 151 procedures ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 151 procedures ⁴⁶	0.00 ⁴⁶
Q3 2010 - Q2 2011 Result 0 infections, 168 procedures ⁴⁶ Rating SIR: 0.00 ⁴⁶	0 infections, 168 procedures ⁴⁶	0.00 ⁴⁶